Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Ventricular Tachycardia Ablation in End-stage Heart Failure Patients With Left Ventricular Assist Device

NCT06063811 is registered in ClinicalTrials.gov with Universitätsklinikum Köln as lead sponsor.

NCT NCT06063811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06063811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Ventricular Tachycardia Ablation in End-stage Heart Failure Patients With Left Ventricular Assist Device
Lead sponsor
Universitätsklinikum Köln
Phase
Observational
Overall status
Unknown status
Start date
September 25, 2023
Completion date
May 15, 2024
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage heart failure, lvad (left ventricular assist device), ventricular arrythmia, ventricular tachycardia